How the world can gear up for the fight against cancer

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Sarbani Chakraborty, Lead, Health Systems Capacity , Roche Here is what we know today: cancer is the second leading cause of death worldwide, claiming nearly 10 million lives in 2018 alone. On top of that, population growth and ageing will […]

Four lessons for a successful switch to value-based healthcare

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Fred Horne, Principal, Horne and Associates & Gabriel Seidman, Project Leader (New York), Boston Consulting Group & Gregory Katz, Chair of Innovation Management & Value in Health, University Paris Descartes Medical School Let’s start with the good news; we […]

The AI doctor won’t see you now

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Geraint Rees, Professor of cognitive neurology, University College London What makes a good doctor? When the British Medical Journal asked the question in 2002, common qualities that resonated with its readers were compassion, understanding, empathy, honesty, competence, commitment and […]

Concorde is a reminder that the only way for innovation is up

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Simon Freakley, Chief Executive Officer, AlixPartners I do not think I have ever met a child who is not fascinated with flying. When an airplane passes overhead and my own children look up at the sky, I can remember […]

Access to healthcare is not enough – high quality care has to be the target

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Harald Nusser, Head of Novartis Social Business, Novartis Universal health coverage (UHC) in lower-income countries has been embraced by global organizations such as the World Health Organization (WHO) and the World Bank. Developing UHC – a system of basic […]

Here’s how to make ‘value-based healthcare’ a reality

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Jan Kimpen, Chief Medical Officer, Philips One thing all healthcare stakeholders agree on is that our global health systems are near breaking point. The ageing population and increasing incidence of chronic disease, innovative technologies and new powerful drugs, have […]

The impact of refugees on the European healthcare system

This article was exclusively written for the Sting by Ms Stavroula Papaeleftheriou. The writer is a fifth year medical student at the University of Medicine and Pharmacy Gr. T. Popa, in Iasi, Romania. She is also affiliated to the International Federation of Medical Students Associations (IFMSA). However, the opinions expressed in this piece belong strictly to the writer and do not necessarily reflect IFMSA’s view […]

Bayer-Monsanto merger: the story of the rise of the “endless company”

When about two weeks ago the world learnt that the German multinational company Bayer, leader in the chemical and pharmaceutical industry, had made an offer to acquire Monsanto, the world’s largest seed company, no one could believe it at first. It sounded so crazy and complex it might have as well needed some time for people […]

Far from a healthy Health Workforce: lack of workforce planning leaves our citizens without access to proper care

This article was exclusively written for the Sting by Ms Stijntje Dijk, Liaison Officer for Medical Education issues at the International Federation of Medical  Students’ Associations (IFMSA). We write to you today as the representatives of medical students worldwide to express our deep concern for the access to healthcare as well as the wellbeing of […]

Pharmaceuticals spend millions to push TTIP while consumer groups spend peanuts

While the EU is dramatically exposed to an unprecedented migration crisis, a new report by the Corporate Europe Observatory (CEO) reveals something that is destined to be largely discussed in the immediate future. The Brussels-based, non-profit research and campaign group, whose aim is to expose any effects of corporate lobbying on EU policy making, last week […]

Pharmaceuticals conceal drug side effects with the EU’s Court blessing

When was the last time you heard about a famous drug that had to be withdrawn from the market after it had cost hundreds or thousands of lives to the patients who had been prescribed with? Did you think it was due to an accident or human error during production? How would you feel if you found […]

Novartis and Johnson & Johnson to deprive Europeans of their right to Health

It was the last day of January that the European Commission decided to send a formal complaint against two pharmaceutical giants, Johnson and Johnson and Novartis, over an illegal secret deal that made European cancer patients suffer while it brought huge profits to the American and Swiss multinational accordingly. After the meticulous research of DG […]

Is there a drug for every disease?

Pharmaceutical firms in Europe have an awkward relation with their customers. The truth is that their selling prices and product licencing are directly or indirectly controlled by the buyers, that is governments, or government control health insurance schemes, offering almost free health services to citizens. As everybody knows governments are not only able to influence […]

Why banks escape from competition rules but not pharmaceutical firms

Antitrust EU Commission services have an excellent record in identifying, monitoring, substantiating with facts and finally punishing cartels and dominant position abuses. This last week two concrete cases stand witnesses to that.Protecting consumers In the first case the European Court of Justice rejected an appeal against a General Court’s decision, which had upheld almost completely […]